Truist Securities raises Genesco stock price target to $25 from $23

Truist Securities raised its Genesco (GCO) price target to $25 from $23, maintaining a Hold rating, following a strong Q1 and reaffirmed EPS guidance. Genesco reported a 4% year-over-year revenue increase to $474 million and a 5% increase in comparable sales, while managing tariff impacts through strategic initiatives and selective price increases; however, analysts remain cautious due to macroeconomic uncertainties and potential demand fluctuations, as reflected in the stock's 41.5% decline over the past six months.

Analysis

Truist Securities has increased its price target for Genesco (GCO) to $25 from $23, while maintaining a Hold rating, a decision influenced by Genesco's strong first-quarter 2025 results and the reaffirmation of its full-year earnings per share guidance. The company reported a 4% year-over-year revenue increase to $474 million, exceeding forecasts, and a 5% increase in comparable sales, with an adjusted diluted loss per share of $2.05, slightly better than the anticipated $2.06 loss. Analysts project a return to profitability for Genesco this year, with forecasted earnings of $1.42 per share. Genesco is actively mitigating the impact of tariffs on its gross margins, which stand at 47.2%, through sourcing, efficiency initiatives, and selective price increases planned for the second half of the fiscal year. The turnaround at its Journeys brand is reportedly gaining momentum, and the company maintains a healthy current ratio of 1.6. Additionally, Genesco has repurchased 5% of its outstanding shares. Despite these positive developments, including an upgrade by analysts noted in other recent news, significant concerns remain regarding the macroeconomic environment and potential consumer demand fluctuations, particularly in response to price adjustments. These concerns are underscored by the stock's 41.5% decline over the past six months and challenging comparisons to a strong holiday season in fiscal year 2025.

Key Decisions for Investors

• Investors should weigh Genesco's positive Q1 performance, reaffirmed guidance, and Journeys brand recovery against the cautious Hold rating, significant recent stock decline, and expressed macroeconomic uncertainties before making investment decisions.
• Monitor consumer response to upcoming price increases in the second half of the fiscal year and evolving macroeconomic conditions, as these will be key determinants of Genesco's ability to navigate demand fluctuations and achieve financial targets.
• Consider the ongoing share repurchase program as a potential positive for shareholder value, but remain mindful of the tariff-related cost pressures and the challenging retail landscape impacting the company's outlook.